Brock Shireman, based in San Diego, CA, US, is currently a Vice President, Head of Chemistry at Rapport Therapeutics, bringing experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Inc. and Johnson & Johnson, P.R.D.. Brock Shireman holds a 2001 - 2003 Post doc in Chemistry @ Stanford University. With a robust skill set that includes Organic Synthesis, Medicinal Chemistry, Neuroscience, Drug Design, Drug Discovery and more, Brock Shireman contributes valuable insights to the industry. Brock Shireman has 1 email on RocketReach.